Accuray (ARAY) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
17 Feb, 2026Executive summary
Announced and began executing a comprehensive transformation plan focused on cost control, accountability, operational efficiency, and a 15% workforce reduction to drive $25 million in annualized operating profitability improvement.
Initiatives include organizational realignment, prioritization of high ROI programs, and expanded service offerings.
Service revenue grew 4% in Q2 and 5% in 1H, driven by install base growth and favorable pricing.
Product revenue declined 26% in Q2 and 25% in 1H, mainly due to lower China sales impacted by tariffs and geopolitical tensions.
Accounts receivable improved, with Days Sales Outstanding at 43 days, 27 days lower than the prior year.
Financial highlights
Q2 FY26 net revenue was $102.2 million, down 12% year-over-year; 1H FY26 revenue was $196.2 million, down 10% year-over-year.
Service revenue grew 4% year-over-year to $57.2 million; product revenue was $45.0 million, down 26%.
Gross margin for Q2 was $24.1 million (23.5%), down from $41.9 million (36.1%) last year.
Adjusted EBITDA for Q2 was a loss of $1.9 million, compared to a positive $9.6 million last year; 1H Adjusted EBITDA was $(6.0) million.
Net loss for Q2 FY26 was $13.8 million, compared to net income of $2.5 million in Q2 FY25.
Outlook and guidance
FY26 revenue guidance revised to $440–$450 million, down from $471–$485 million.
Adjusted EBITDA guidance lowered to $22–$25 million from $31–$35 million.
Guidance reflects continued volatility in China, persistent tariffs, and macroeconomic headwinds, but assumes no material worsening.
Targeting a high single-digit adjusted EBITDA margin run rate within nine months, aiming for double digits longer term.
Latest events from Accuray
- Shelf registration covers resale of 7M shares from warrants tied to recent financing.ARAY
Registration Filing17 Feb 2026 - Record Q4 revenue and robust FY25 outlook highlight strong growth and global expansion.ARAY
Q4 20241 Feb 2026 - Growth driven by innovation, emerging markets, and margin expansion, with U.S. recovery expected.ARAY
Jefferies Global Healthcare Conference31 Jan 2026 - FY2025 guidance raised as China growth and service gains offset margin and revenue declines.ARAY
Q1 202516 Jan 2026 - Q3 FY25 revenue up 12%, net loss narrowed, but guidance cut on tariffs; EBITDA improved.ARAY
Q3 202527 Dec 2025 - Q2 revenue up 8% to $116.2M, net income $2.5M, margin 36.1%, guidance raised.ARAY
Q2 202524 Dec 2025 - Resale registration covers 23.4M shares from warrant exercises tied to recent financing.ARAY
Registration Filing16 Dec 2025 - Shareholders will vote on director elections, equity plan increases, pay, and auditor ratification.ARAY
Proxy Filing1 Dec 2025 - Major leadership changes and transformation plan target growth, margin expansion, and agility.ARAY
Proxy Filing1 Dec 2025